GlucoTrack Inc

GlucoTrack Inc(GCTK)财务数据

$4.230

-0.062 (-1.47%)收盘时

GCTK 盈利能力与利润率

Evaluating the bottom line, GlucoTrack Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -527.20%, provide a clear picture of how effectively GCTK converts its operational activities into shareholder value.

GCTK 同业对比

In the context of the broader market, GCTK competes directly with industry leaders such as BIAF and NUWE. With a market capitalization of $2.98M, it holds a significant position in the sector. When comparing efficiency, GCTK's gross margin of N/A stands against BIAF's 23.91% and NUWE's 76.08%. Such benchmarking helps identify whether GlucoTrack Inc is trading at a premium or discount relative to its financial performance.

GlucoTrack Inc 财务表现

GlucoTrack has reported continuous net losses, with the latest net income showing a loss of $4,334,000 in Q1 2026. The company's current ratio is low at 0.85, indicating potential liquidity issues.

Financials

FY2021Q1
0.00
Total Revenue
FY2026Q1
YoY:
+20.15%
-4.20M
Operating Profit
FY2026Q1
YoY:
-36.57%
-4.33M
Net Income after Tax
FY2026Q1
YoY:
-93.43%
-2.65
EPS - Diluted
FY2026Q1
YoY:
+37.31%
-4.05M
Free Cash Flow

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始